John Jesitus
- Indexed articles, last 90 days
- 2
- Latest publication
- Sep 15, 2026
- Outlet visibility, for Medscape
- Top 50K sites
- Earliest in this view
- Aug 17, 2026
Latest articles
Pediatric Atopic Dermatitis: Biologic Revolution Continues (opens the original)
Read excerpt
This is part of the third installment of a series on biologics and dermatology, exploring the impact of biologics on the treatment of dermatologic diseases. The FDA’s 2019 approval of dupilumab for moderate-to-severe atopic dermatitis (AD) in children aged 12-17 years created a turning point whose momentum continues today as dermatologists await pediatric approvals of additional biologics and JAK inhibitors, which are already approved for AD in adults. Additional biologic approvals are expected
Antioxidants in Vitiligo: Experts Support Select Ingredients (opens the original)
Read excerpt
As antioxidants remain a controversial tool for vitiligo therapy worldwide, experts advise sticking with evidence-based options, which include several supported by clinical studies: combined vitamin C, vitamin E, and alpha-lipoic acid (ALA); Ginkgo biloba; and Polypodium leucotomos. Perhaps joining this list, they told Medscape Dermatology, is a specially formulated superoxide dismutase (SOD) that was found to improve the efficacy of phototherapy in a recently published study of patients with vi
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
Top 50K sites
For Medscape, the outlet · Measured Aug 1, 2026
Website popularity band, not a count of readers or article views.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.